J. Schubert

Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17

E. Hagström, A. Allahyari, P. Ueda, 2020, European heart journal. Quality of care & clinical outcomes.

Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study

E. Hagström, H. Melhus, P. Ueda, 2020, European heart journal.

Angina intensity is not different in diabetic and non-diabetic patients with acute myocardial infarction

D. Tschoepe, R. Schiele, A. Gitt, 2003, Zeitschrift für Kardiologie.

Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across sixteen countries

J. De Sutter, P. Woudstra, P. van der Harst, 2021, medRxiv.

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

Diane M. Miller, Natalia E. Shilkina, M. C. Cantero, 2018, Lancet.

Elevated low‐density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction

E. Hagström, H. Melhus, P. Ueda, 2023, Journal of internal medicine.